000 01655 a2200493 4500
005 20250514184507.0
264 0 _c20040826
008 200408s 0 0 spa d
022 _a0301-0546
024 7 _a10.1016/s0301-0546(04)79235-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarmendia Zallo, M
245 0 0 _a[Cross reactivity among proton pump inhibitors: does it exits?].
_h[electronic resource]
260 _bAllergologia et immunopathologia
_c
300 _a92-5 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _a2-Pyridinylmethylsulfinylbenzimidazoles
650 0 4 _aAdult
650 0 4 _aAngioedema
_xetiology
650 0 4 _aBenzimidazoles
_ximmunology
650 0 4 _aCross Reactions
650 0 4 _aDrug Eruptions
_xetiology
650 0 4 _aEnzyme Inhibitors
_xadverse effects
650 0 4 _aFemale
650 0 4 _aGastroesophageal Reflux
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImmunoglobulin E
_ximmunology
650 0 4 _aIntradermal Tests
650 0 4 _aLansoprazole
650 0 4 _aLaryngeal Edema
_xetiology
650 0 4 _aOmeprazole
_xadverse effects
650 0 4 _aPantoprazole
650 0 4 _aProton Pump Inhibitors
650 0 4 _aPruritus
_xetiology
650 0 4 _aSkin Tests
650 0 4 _aSulfoxides
_ximmunology
700 1 _aSánchez Azkarate, A
700 1 _aKraemer Mbula, R
700 1 _aLiarte Ruano, I
700 1 _aNuñez Hernandez, A
700 1 _aCid De Rivera, C
773 0 _tAllergologia et immunopathologia
_gvol. 32
_gno. 2
_gp. 92-5
856 4 0 _uhttps://doi.org/10.1016/s0301-0546(04)79235-6
_zAvailable from publisher's website
999 _c14800420
_d14800420